2010 (v1)
Publication
The addition of Rituximab (anti-CD20 monoclonal antibody) to chemotherapy has dramatically increased survival of non-Hodgkin's lymphoma (NHL) patients. However, in view of the intrinsic immunosuppressive effect of this drug, new questions are emerging in clinical practice. Among these, the assessment and proper interpretation of HBV serological...
Uploaded on: April 14, 2023